4.8 Article

Global hyperactivation of enhancers stabilizes human and mouse naive pluripotency through inhibition of CDK8/19 Mediator kinases

Journal

NATURE CELL BIOLOGY
Volume 22, Issue 10, Pages 1223-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41556-020-0573-1

Keywords

-

Categories

Funding

  1. Leverhulme Trust early career fellowship
  2. Wellcome Trust [098287/Z/12/Z]
  3. European Research Council (ERC) [669198]
  4. Secretaria d'Universitats i Recerca de la Generalitat de Catalunya
  5. European Social Fund
  6. Fondation pour la Recherche Medicale [DEQ20170336757]
  7. Infrastructure Nationale en Biologie et Sante INGESTEM [ANR-11-INBS-0009]
  8. IHU-B CESAME [ANR-10-IBHU-003]
  9. LabEx REVIVE [ANR-10-LABX-73]
  10. LabEx DEVweCAN [ANR-10-LABX-0061]
  11. LabEx CORTEX of University of Lyon within the programme 'Investissements d'Avenir' [ANR-11-LABX-0042, ANR-11-IDEX-0007]
  12. Spanish Ministry of Economy and Competitiveness [SAF2013-44267-R]
  13. CNIO
  14. Institut National du Cancer [PLBIO10-068, PLBIO15-005]
  15. Ligue National Contre le Cancer [EL2018.LNCC/DF]
  16. ERC, under the European Union Horizon 2020 research and innovation programme [StG-2014-640525_REGMAMKID]
  17. Spanish Association Against Cancer [AECC/LABAE16006]
  18. Carlos III Health Institute (Red TerCel, CardioCel) [RD16/0011/0027]
  19. Ministry of Economy and Competitiveness (MINECO) [SAF2017-89782-R, SAF2015-72617-EXP, RYC-2014-16242]
  20. CERCA/Government of Catalonia [2017 SGR 1306]
  21. MINECO Spain [SAF2013-44866-R]
  22. Plan Nacional de I+D+I 2013-2016/FEDER [PI15/00892]
  23. ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion [CP11/00131]
  24. IUOPA
  25. Asturias Regional Government [GRUPIN14-052]
  26. Obra Social Liberbank-Cajastur, Spain
  27. IRB
  28. Spanish Ministry of Economy - European Regional Development Fund [SAF2017-82613-R]
  29. ERC [ERC-2014-AdG/669622]
  30. Botin Foundation
  31. Banco Santander (Santander Universities Global Division)
  32. laCaixa Foundation
  33. Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement of Catalonia (Grup de Recerca consolidat) [2017 SGR 282]
  34. Plan Nacional de I+D+I 2008-2011/FEDER [CP11/00131]

Ask authors/readers for more resources

Lynch et al. demonstrate that inhibiting CDK8 and CDK19 kinases increases Mediator-driven recruitment of RNA Pol II to promoters and enhancers, therefore stabilizing the naive transcriptional program. Pluripotent stem cells (PSCs) transition between cell states in vitro, reflecting developmental changes in the early embryo. PSCs can be stabilized in the naive state by blocking extracellular differentiation stimuli, particularly FGF-MEK signalling. Here, we report that multiple features of the naive state in human and mouse PSCs can be recapitulated without affecting FGF-MEK signalling or global DNA methylation. Mechanistically, chemical inhibition of CDK8 and CDK19 (hereafter CDK8/19) kinases removes their ability to repress the Mediator complex at enhancers. CDK8/19 inhibition therefore increases Mediator-driven recruitment of RNA polymerase II (RNA Pol II) to promoters and enhancers. This efficiently stabilizes the naive transcriptional program and confers resistance to enhancer perturbation by BRD4 inhibition. Moreover, naive pluripotency during embryonic development coincides with a reduction in CDK8/19. We conclude that global hyperactivation of enhancers drives naive pluripotency, and this can be achieved in vitro by inhibiting CDK8/19 kinase activity. These principles may apply to other contexts of cellular plasticity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available